Mohan M Rajapurkar
Overview
Explore the profile of Mohan M Rajapurkar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
514
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Patel J, Patel M, Koringa P, Shah T, Patel A, Tripathi A, et al.
Indian J Hum Genet
. 2013 Sep;
19(2):219-32.
PMID: 24019626
Background: Human leukocyte antigen (HLA) is comprised of a highly polymorphic set of genes which determines the histocompatibility of organ transplantation. The present study was undertaken to identify HLA class...
12.
Singh A, Farag Y, Mittal B, Karai Subramanian K, Keithi Reddy S, Acharya V, et al.
BMC Nephrol
. 2013 May;
14:114.
PMID: 23714169
Background: There is a rising incidence of chronic kidney disease that is likely to pose major problems for both healthcare and the economy in future years. In India, it has...
13.
Lele S, Mukhopadhyay B, Mardikar M, Patel T, Vasavada A, Banker D, et al.
Am Heart J
. 2013 Apr;
165(5):744-51.
PMID: 23622911
Background: Catalytic iron (CI) mediates vascular injury by generating reactive oxygen species. We evaluated role of CI in predicting mortality in patients with acute coronary syndrome (ACS) and studied association...
14.
Steen D, Cannon C, Lele S, Rajapurkar M, Mukhopadhyay B, Scirica B, et al.
Clin Cardiol
. 2013 Feb;
36(3):139-45.
PMID: 23377899
Background: The potential of iron to generate reactive oxygen species has motivated a long-standing interest in whether excess iron is causally linked to atherosclerotic heart disease. Circulating catalytic iron ("free"...
15.
Rajapurkar M, Hegde U, Bhattacharya A, Alam M, Shah S
Toxicol Mech Methods
. 2012 Sep;
23(1):5-10.
PMID: 22978744
Compelling experimental evidence exists for the role of oxidants and iron in glomerular disease. In preliminary studies, we confirmed increased urinary catalytic iron in patients with glomerulonephritis and diabetic nephropathy....
16.
Rajapurkar M, John G, Kirpalani A, Abraham G, Agarwal S, Almeida A, et al.
BMC Nephrol
. 2012 Mar;
13:10.
PMID: 22390203
Background: There are no national data on the magnitude and pattern of chronic kidney disease (CKD) in India. The Indian CKD Registry documents the demographics, etiological spectrum, practice patterns, variations...
17.
Rajapurkar M, Shah S, Lele S, Hegde U, Lensing S, Gohel K, et al.
Am J Cardiol
. 2011 Nov;
109(3):438-42.
PMID: 22071209
The ability of iron to cycle reversibly between its ferrous and ferric oxidation states is essential for the biological functions of iron but may contribute to vascular injury through the...
18.
Shah S, Rajapurkar M, Baliga R
Clin J Am Soc Nephrol
. 2011 Oct;
6(10):2329-31.
PMID: 21979910
No abstract available.
19.
Shah S, Rajapurkar M
Hemoglobin
. 2009 Oct;
33(5):378-85.
PMID: 19821781
There are two major forms of kidney disease: acute renal failure [also referred to as acute kidney injury (AKI)] and chronic kidney disease (CKD). Acute renal failure is an abrupt...
20.
Mishra S, Muthu V, Rajapurkar M, Desai M
Indian J Urol
. 2009 Sep;
23(3):299-304.
PMID: 19718334
Structural urologic abnormalities resulting in dysfunctional lower urinary tract leading to end stage renal disease may constitute 15% patients in the adult population and up to 20-30% in the pediatric...